News

CarParts.com Announces 2025 Q1 Financial Outcomes and Plans

CarParts.com Announces 2025 Q1 Financial Outcomes and Plans

CarParts.com Releases First Quarter Results for 2025

CarParts.com, Inc. (NASDAQ: PRTS), a leader in eCommerce for automotive parts and accessories, has issued its financial results for the first quarter of 2025.

Financial Summary for Q1 2025

In an insightful turn of events, the company recognized a significant drop in net sales, which fell 11% to $147.4 million compared to the previous year’s same quarter. Likewise, gross profits decreased to $47.3 million from $53.9 million, leading to a gross margin decrease to 32.1% from 32.4%, primarily driven by a rise in outbound freight costs.

Detailed Breakdown of Financial Performance

The first quarter data reveals some challenges, including a net loss of $15.3 million or $0.27 per share. This compares unfavorably to the $6.5 million net loss in the prior year, largely due to escalating marketing expenses and unfavorable profit margins.

Adjusted EBITDA also dipped to ($6.2) million, contrasting with a positive $1.1 million from the year-ago quarter, reflecting softer consumer demand and higher competition in performance marketing.

Positive Trends and Strategic Directions

Despite these challenges, management has observed a positive shift in the company's operations during the first six weeks of the second quarter, achieving double-digit revenue growth year-over-year on reduced marketing spending. CEO David Meniane claims that strong emphasis on repeat customers, growth in mobile traffic, and higher-margin fee income are reflecting positively on the business.

The leadership is committed to improving profitability by targeting wealthier consumers and diversifying customer acquisition strategies. This focus aims to balance out external pressures affecting the company's margin stability. The intention is to upgrade customer engagement through the mobile app, which now boasts around 900,000 downloads.

Future Outlook

As a forward-thinking company, CarParts.com is assessing various strategic alternatives in response to inquiries about growth options. However, they have opted against providing specific financial guidance for 2025 at this time.

Upcoming Conferences and Investor Relations

Key executive figures from CarParts.com, including David Meniane and CFO Ryan Lockwood, are set to conduct an investor conference call to discuss their latest results, providing deeper insights into the company's strategies moving forward.

The leadership encourages stakeholders to keep an eye on developments that might signal shifts in financial performance.

About CarParts.com, Inc.

CarParts.com, Inc. is a technology-driven eCommerce platform dedicated to providing a vast selection of over 1 million quality automotive parts and accessories. The company's emphasis on customer service is evident in its user-friendly, mobile optimized website and application. Over its 25 years in business, CarParts.com has established a trustworthy reputation in delivering repair and maintenance solutions, placing emphasis on customer satisfaction and affordability.

CarParts.com’s mission is Empowering Drivers Along Their Journey, and it continuously seeks to enhance the value delivered to customers through innovative solutions and efficient delivery networks.

Frequently Asked Questions

What were the total net sales reported for Q1 2025?

The total net sales for Q1 2025 were $147.4 million, which marks an 11% decrease compared to the previous year.

How did the company's gross profit change in Q1 2025?

The gross profit decreased to $47.3 million in Q1 2025 from $53.9 million in Q1 2024.

What strategic measures is CarParts.com implementing?

CarParts.com is focusing on acquiring higher-income customers and diversifying its acquisition strategies, while heavily investing in its mobile app to increase customer lifetime value.

What is CarParts.com's cash balance as of Q1 2025?

The company holds a cash balance of $38.5 million with no revolving debt, reflecting improved financial management.

What are the future prospects for CarParts.com?

The company is exploring various strategic alternatives related to growth and market positioning, thus it is currently refraining from providing specific financial guidance for 2025.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 154

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 122

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 207

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 22

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 225

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 155

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 150

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 233

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
les" class="btn" href="https://investorshangout.com/blog/news?page=2">More News Articles